Described herein is a composition for use in preventing or minimising epigenetic changes to one or more genes responsible for mediating inflammatory response in an animal. The composition contains beta-casein. The beta-casein comprises at least 50% by weight of beta-casein variants having proline at position 67 of the beta-casein amino acid sequence.